T2 Biosystems, Inc.
USD0.00
+0.00 (+0.00%)
CEO
Craig R. Jalbert
IPO Date
2014-08-07
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
OTC
Country
US
Open
$0.01
Prev. Close
$0.00
Day Low
$0.00
Day High
$0.01
52W Low
$0.00
52W High
$0.16
Market Cap
$0.00B
Volume
0.00M
| 190,000 |
| $0.00 |
| 2 Jan 2025 | Elsbree David B | director | A-Award | Acquired | 25,000 | $0.00 |
| 2 Jan 2025 | Sperzel John J III | director, officer: See Remarks | A-Award | Acquired | 490,000 | $0.00 |
| 2 Jan 2025 | CUMMING JOHN W | director | A-Award | Acquired | 35,000 | $0.00 |
| 2 Jan 2025 | Saunders Ninfa | director | A-Award | Acquired | 25,000 | $0.00 |
| 2 Jan 2025 | Toft Robin | director | A-Award | Acquired | 25,000 | $0.00 |
| 2 Jan 2025 | LIEBMAN SEYMOUR | director | A-Award | Acquired | 25,000 | $0.00 |
| 17 Sept 2024 | Elsbree David B | director | S-Sale | Disposed | 55 | $2.42 |
| 13 May 2024 | CR Group L.P. | 10 percent owner | C-Conversion | Acquired | 108,752 | $0.00 |